R Ignoffo
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
Papers in
- Oncology 6
- Colorectal Cancer Treatments and Studies 2
- Cancer Treatment and Pharmacology 2
- Pancreatic and Hepatic Oncology Research 2
-
- Angiogenesis and VEGF in Cancer 1
- Co-authors
- Robert Stagg (2 shared papers)B.J. Lewis (2 shared papers)Michael Friedman (2 shared papers)David C. Hohn (1 shared paper)Anthony A. Rayner (1 shared paper)John F. Hannigan (1 shared paper)Joel Z. Melnick (1 shared paper)Douglas G. Altman (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer Practice (1 paper)PubMed (4 papers)
- Partner nations
- United States
In The Last Decade
R Ignoffo
7 papers receiving 610 citations
Peers
Comparison fields: 5 of 71
- Hepatology 361
- Otorhinolaryngology 81
- Oncology 385
- Pulmonary and Respiratory Medicine 225
- Surgery 224
Countries citing papers authored by R Ignoffo
This map shows the geographic impact of R Ignoffo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Ignoffo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Ignoffo more than expected).
Fields of papers citing papers by R Ignoffo
This network shows the impact of papers produced by R Ignoffo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Ignoffo. The network helps show where R Ignoffo may publish in the future.
Co-authors
The 25 scholars most cited alongside R Ignoffo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 349 | |
| 2 | Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. | 1996 | 130 |
| 3 | 1985 | 122 | |
| 4 | Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response. | 1985 | 17 |
| 5 | Adriamycin-cyclophosphamide treatment of squamous cell carcinoma of the cervix. | 1978 | 7 |
| 6 | 1998 | 7 | |
| 7 | Dolasetron. A new 5-hydroxytryptamine3 receptor antagonist. | 1997 | 1 |
About R Ignoffo
R Ignoffo is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Hepatology and Otorhinolaryngology, having authored 7 papers that have together received 633 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Cancer Treatment and Pharmacology (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Lung Cancer Treatments and Mutations (1 paper), Oral health in cancer treatment (1 paper) and Endometrial and Cervical Cancer Treatments (1 paper). The work is most often cited by research in Hepatology (361 citations), Otorhinolaryngology (81 citations), Oncology (385 citations), Pulmonary and Respiratory Medicine (225 citations) and Surgery (224 citations). R Ignoffo has collaborated with scholars based in United States. Frequent co-authors include Robert Stagg, B.J. Lewis, Michael Friedman, David C. Hohn, Anthony A. Rayner, John F. Hannigan, Joel Z. Melnick, Douglas G. Altman, D. Höhn and W. Hauck. Their work appears in journals such as Journal of Clinical Oncology, Cancer Practice and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.